오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - water for injections, quantity: 5 ml - injection, solution - excipient ingredients: - water for injections is used for the reconstitution and preparation of aqueous injections.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - water for injections, quantity: 2 ml - injection, solution - excipient ingredients: - water for injections is used for the reconstitution and preparation of aqueous injections.

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals uc - triamcinolone acetonide - suspension for injection - 10 milligram(s)/millilitre - glucocorticoids; triamcinolone

필리핀 - 영어 - FDA (Food And Drug Administration)

pan-jet pharmaceuticals corp.; distributor: pan-jet pharmaceuticals corp. - ceftriaxone (as sodium) - powder for injection - 1 g

필리핀 - 영어 - FDA (Food And Drug Administration)

pan-ject pharmaceutcial corporation; distributor: pan-ject pharmaceutcial corporation - cefuroxime(as sodium) - powder for injection - 750mg vial

필리핀 - 영어 - FDA (Food And Drug Administration)

pan-ject pharmaceuticals corp.; distributor: pan-ject pharmaceuticals corp. - metronidazole - solution for iv infusion - 5mg/ml

유럽 연합 - 영어 - EMA (European Medicines Agency)

allergan pharmaceuticals international ltd - pancreas powder - exocrine pancreatic insufficiency - digestives, incl. enzymes - pancreatic enzyme replacement treatment in exocrine pancreatic insufficiency due to cystic fibrosis or other conditions (e.g. chronic pancreatitis, post pancreatectomy or pancreatic cancer).enzepi is indicated in infants, children, adolescents and adults.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 3 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

takeda pharmaceuticals australia pty ltd - water for injections, quantity: 0.5 ml - injection, solution - excipient ingredients: - revestive is indicated for the treatment of adult and paediatric patients 2 years of age and above with short bowel syndrome (sbs) who are dependent on parenteral support.,patients should be stable for at least 4 weeks on their parenteral support regimen before initiating teduglutide therapy

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - droperidol, quantity: 5 mg - injection, solution - excipient ingredients: mannitol; tartaric acid; sodium hydroxide; water for injections - anaesthesia droperidol droperidol lupin is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia in neuroleptanalgesia in which droperidol lupin injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.